NUCLEOCYTOPLASMIC TRANSPORT--NEW FACTORS AND PATHWAYS
核质转运--新因素和途径
基本信息
- 批准号:6386900
- 负责人:
- 金额:$ 19.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-05-01 至 2003-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Various classes of proteins and nucleic acids are imported into and
exported out of the cell nucleus through separate pathways, defined by
independent sets of carrier molecules and docking sites ad the nuclear
pore complexes. For some transported species the components of their
transport machineries are partially or totally unknown. Our aim is to
identify and characterize new nucleocytoplasmic transport factors, based
on two complementary strategies. The first approach involves obtaining the
full DNA sequences of potential transport factors whose existence is
inferred from the presence in the GenBank EST database of shot, partial
cDNA sequences, showing significant homology with known transport factors.
The second strategy is based on the fact that all known transport factors
dock temporarily, during passage across the nuclear pore, to proteins at
the nuclear pore complexes. One of these docking site proteins, Nup98,
which we isolated and shown to be implicated in multiple transport
pathways, will be used for retention and isolation of new transport
factors from the nucleoplasm. The proteins isolated by these two
approaches will be characterized in terms of full cDNA sequence,
subcellular localization, and level of expression in various tissues and
developmental stages. Most importantly, the proteins interacting with
these transport factors will be identified by co-immunoprecipitation,
screening of expression libraries, and two-hybrid assays. The ensemble of
these data, and especially the set of interacting molecules, will shed
light on the specific functions of these proteins as transport factors.
The relevance of these studies for human health is linked to the fact that
a vast number of proteins and nucleic acids cannot exert their function
unless they are imported in or exported out of the nucleus in a precise
manner, and in fact there are known cases when tumors arise due to defects
in nucleocytoplasmic transport pathways are used by viruses, knowing in
detail these mechanisms could also offer opportunities for new anti-viral
therapies and for improved gene therapy vectors.
各种类型的蛋白质和核酸被输入到细胞中,
通过不同的途径从细胞核输出,定义为
独立的载体分子组和与核的对接位点
孔隙复合体对于某些被运输的物种,
运输机械部分或全部未知。我们的目标是
鉴定和表征新的核质转运因子,
两个互补的战略。第一种方法涉及获得
潜在转运因子的完整DNA序列,其存在是
从GenBank EST数据库中存在的镜头,部分
cDNA序列,与已知的转运因子显示出显着的同源性。
第二种策略是基于这样一个事实,即所有已知的运输因素
在穿过核孔的过程中暂时停靠在蛋白质上,
核孔复合体。其中一个对接点蛋白Nup98,
我们分离出了它,并证明它与多种运输有关,
通道,将用于保留和隔离新的运输
来自核质的因子。这两个人分离出的蛋白质
方法的特征在于全cDNA序列,
亚细胞定位和在各种组织中的表达水平,
发育阶段最重要的是,蛋白质与
这些转运因子将通过免疫共沉淀来鉴定,
表达文库的筛选和双杂交测定。述全体
这些数据,尤其是相互作用的分子,
了解这些蛋白质作为转运因子的特殊功能。
这些研究与人类健康的相关性与以下事实有关:
大量的蛋白质和核酸不能发挥它们的功能,
除非它们以精确的方式输入或输出核
方式,事实上,有已知的情况下,当肿瘤出现由于缺陷
在核质转运途径中,
详细说明这些机制也可以为新的抗病毒药物提供机会。
治疗和改进的基因治疗载体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AURELIAN RADU其他文献
AURELIAN RADU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AURELIAN RADU', 18)}}的其他基金
A new highly sensitive targeted imaging method for early tumor detection
一种用于早期肿瘤检测的新型高灵敏度靶向成像方法
- 批准号:
10651258 - 财政年份:2023
- 资助金额:
$ 19.23万 - 项目类别:
MRI AND NEAR-INFRARED IMAGING OF THE TUMOR VASCULATURE VIA A NEW MARKER
通过新标记物对肿瘤血管进行 MRI 和近红外成像
- 批准号:
8240999 - 财政年份:2011
- 资助金额:
$ 19.23万 - 项目类别:
MRI AND NEAR-INFRARED IMAGING OF THE TUMOR VASCULATURE VIA A NEW MARKER
通过新标记物对肿瘤血管进行 MRI 和近红外成像
- 批准号:
8094075 - 财政年份:2011
- 资助金额:
$ 19.23万 - 项目类别:
NON-VIRAL GENE THERAPY VECTORS--EFFICIENT NUCLEAR IMPORT
非病毒基因治疗载体——高效的核导入
- 批准号:
2824089 - 财政年份:1999
- 资助金额:
$ 19.23万 - 项目类别:
NON-VIRAL GENE THERAPY VECTORS--EFFICIENT NUCLEAR IMPORT
非病毒基因治疗载体——高效的核导入
- 批准号:
6177444 - 财政年份:1999
- 资助金额:
$ 19.23万 - 项目类别:
NUCLEOCYTOPLASMIC TRANSPORT--NEW FACTORS AND PATHWAYS
核质转运--新因素和途径
- 批准号:
6181145 - 财政年份:1998
- 资助金额:
$ 19.23万 - 项目类别:
NUCLEOCYTOPLASMIC TRANSPORT--NEW FACTORS AND PATHWAYS
核质转运--新因素和途径
- 批准号:
6519885 - 财政年份:1998
- 资助金额:
$ 19.23万 - 项目类别:
NUCLEOCYTOPLASMIC TRANSPORT--NEW FACTORS AND PATHWAYS
核质转运--新因素和途径
- 批准号:
2910425 - 财政年份:1998
- 资助金额:
$ 19.23万 - 项目类别:
NUCLEOCYTOPLASMIC TRANSPORT--NEW FACTORS AND PATHWAYS
核质转运--新因素和途径
- 批准号:
2602755 - 财政年份:1998
- 资助金额:
$ 19.23万 - 项目类别:
相似海外基金
CAREER: Elucidating spatial and epigenetic regulation of gene expression during human development using photopatterning and single-cell multiomics
职业:利用光模式和单细胞多组学阐明人类发育过程中基因表达的空间和表观遗传调控
- 批准号:
2339849 - 财政年份:2024
- 资助金额:
$ 19.23万 - 项目类别:
Continuing Grant
CAREER: Scalable algorithms for regularized and non-linear genetic models of gene expression
职业:基因表达的正则化和非线性遗传模型的可扩展算法
- 批准号:
2336469 - 财政年份:2024
- 资助金额:
$ 19.23万 - 项目类别:
Continuing Grant
CAREER: Epigenetic Regulation of Gene Expression in Engineered Prokaryotes
职业:工程原核生物基因表达的表观遗传调控
- 批准号:
2338573 - 财政年份:2024
- 资助金额:
$ 19.23万 - 项目类别:
Continuing Grant
MFB: RNA modifications of frameshifting stimulators: cellular platforms to engineer gene expression by computational mutation predictions and functional experiments
MFB:移码刺激器的RNA修饰:通过计算突变预测和功能实验来设计基因表达的细胞平台
- 批准号:
2330628 - 财政年份:2024
- 资助金额:
$ 19.23万 - 项目类别:
Standard Grant
22-BBSRC/NSF-BIO Building synthetic regulatory units to understand the complexity of mammalian gene expression
22-BBSRC/NSF-BIO 构建合成调控单元以了解哺乳动物基因表达的复杂性
- 批准号:
BB/Y008898/1 - 财政年份:2024
- 资助金额:
$ 19.23万 - 项目类别:
Research Grant
How does the chromatin remodeller CHD4 regulate gene expression?
染色质重塑因子 CHD4 如何调节基因表达?
- 批准号:
DP240102119 - 财政年份:2024
- 资助金额:
$ 19.23万 - 项目类别:
Discovery Projects
Data-driven model links BMIz to gene expression in pediatric asthma
数据驱动模型将 BMIz 与小儿哮喘基因表达联系起来
- 批准号:
493135 - 财政年份:2023
- 资助金额:
$ 19.23万 - 项目类别:
Regulation of gene expression by the La and La-related proteins
La 和 La 相关蛋白对基因表达的调节
- 批准号:
489704 - 财政年份:2023
- 资助金额:
$ 19.23万 - 项目类别:
Operating Grants
Investigating the role of SARS-CoV-2 and MERS-CoV transcription regulatory sequence (TRS) in viral gene expression and virulence
研究 SARS-CoV-2 和 MERS-CoV 转录调控序列 (TRS) 在病毒基因表达和毒力中的作用
- 批准号:
494272 - 财政年份:2023
- 资助金额:
$ 19.23万 - 项目类别:
Operating Grants
Application for 2024 CIHR NIF (ECR): Investigating the role of SARS-CoV-2 and MERS-CoV transcription regulatory sequence (TRS) in viral gene expression and virulence
2024 CIHR NIF (ECR) 申请:研究 SARS-CoV-2 和 MERS-CoV 转录调控序列 (TRS) 在病毒基因表达和毒力中的作用
- 批准号:
491942 - 财政年份:2023
- 资助金额:
$ 19.23万 - 项目类别:














{{item.name}}会员




